Eiko Lifesciences Ltd
BSE: 540204
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 15.90+66.1% | 9.57+4.1% | 9.20+23.4% | 7.45+5.1% | 7.09+2.6% | 6.91-10.7% | 7.74 |
| Other Income | 0.45-18.3% | 0.56-1.5% | 0.56+2.0% | 0.55+5.2% | 0.53+401.3% | 0.10-19.8% | 0.13 |
| Total Income | 16.36+61.5% | 10.13+3.8% | 9.76+21.9% | 8.01+5.1% | 7.62+8.6% | 7.01-10.9% | 7.87 |
| EXPENSES | |||||||
| Expenditure | 14.86+67.3% | 8.89+2.2% | 8.69+22.5% | 7.10+5.0% | 6.76+1.9% | 6.63-12.6% | 7.59 |
| Tax | 0.37+24.6% | 0.30+18.4% | 0.25+16.2% | 0.22-26.9% | 0.29+207.1% | 0.10+33.3% | 0.07 |
| PROFIT | |||||||
| PBT | 1.49+20.0% | 1.24+16.5% | 1.07+17.7% | 0.91-24.1% | 1.20+213.9% | 0.38+36.1% | 0.28 |
| Net Profit | 1.12+18.6% | 0.95+15.9% | 0.82+18.1% | 0.69-23.2% | 0.90+216.1% | 0.28+37.0% | 0.21 |
| KEY METRICS | |||||||
| OPM % | 7.70%-1.41pp | 9.11%+1.28pp | 7.83%+0.86pp | 6.97%-5.09pp | 12.06%+10.64pp | 1.42%+2.07pp | -0.65% |
| NPM % | 6.87%-2.48pp | 9.35%+0.98pp | 8.37%-0.28pp | 8.65%-3.18pp | 11.83%+7.77pp | 4.06%+1.42pp | 2.64% |
| EPS | 0.80+15.9% | 0.69+15.0% | 0.60+20.0% | 0.50-27.5% | 0.69+187.5% | 0.24+50.0% | 0.16 |
Corporate Events
Board MeetingEIKO
202626May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingEIKO
202511Dec
Board Meeting
Proposal for raising of funds by way of issue of one or more…
BSE Filing ↗ Board MeetingEIKO
202419Oct
Board Meeting
Considering and approving The Unaudited Financial Results (S…
BSE Filing ↗ Board MeetingEIKO
202413Aug
Board Meeting
Unaudited Quarterly Financial Results (Standalone And Consol…
BSE Filing ↗ Board MeetingEIKO
202413May
Board Meeting
Consider and approve Audited Financial Results for the quart…
BSE Filing ↗